The global pharmaceutical and biotechnology machines market to grow at robust 5.89% CAGR during the 2021-2028 period. The market is expected to reach a promising valuation of USD 73 billion, rising from just 9 billion in 2009. The growing innovation and competition between the Asia Pacific, and North American players, along with streamlining of approvals from regulatory agencies, and growing demand for biotechnology solutions worldwide with advancements in gene cell, gene therapy, and other solutions will drive growth. The global pharmaceutical and biotechnology equipment market is a competitive, and innovative landscape, thanks to the increasing demand for gene cell therapy in treatment of chronic illnesses like cancer, diabetes, Alzheimer’s, among others. The chronic diseases remain the leading cause of fatalities worldwide, and costs as much as 60% of the burden experienced by healthcare agencies in the North America region. The growing demand for treatment of chronic illnesses, increasing adoption of therapies, and other supplementary treatment to provide relief to patients, and increased productivity of research due to technologies like cell culture, machine learning, and 3D printing will drive new growth avenues for key players in the global pharmaceutical and biotechnology machines market. Some key players in the global pharmaceutical and biotechnology machines market are SOL Group, Taiyo Nippon Sanso,Shenzhen, Sicgil India Limited, Gaofa,Shenwei Medical, and Praxair. Despite increasing competition, collaboration, and mergers also remain the key highlight among leading players, thanks to rising demand for innovation, and increased need to drive patents worldwide.
The machines in the biotechnology and pharmaceutical industry are largely used for the process of separation. The sepration process is essential to differentiate elements during research, and apply them with the pure ingredients in the process of application, and production. The process separation is critical for chromatography, cell culture, identification of ingredients, and manufacturing of drugs. The recombinant protein purification is also becoming essential in the global pharmaceutical and biotechnology machines market as therapies like gene therapy are becoming crucial in the treatment of chronic illnesses. These processes can manipulate and modify organisms, usually at molecular level to provide a robust identification, application, and production for a wide variety of biotechnology processes.
Market segment by Type, covers
Others(Nitrogen, Carbon Dioxide and Helium)
Market segment by Application can be divided into
Hospitals (Labs & Clinics)
Pharmaceutical & Biotechnology Industries
The key market players for global Pharmaceutical and Biotechnology Machines market are listed below:
Taiyo Nippon Sanso
Atlas Copco AB
Sicgil India Limited
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The coronavirus pandemic continues to loom large on a global stage, as various private and public entities continue to find the right tools to find new solutions to tackle the pandemic. This has led to robust demand, as public funds like Melinda and Gates foundation have contributed significantly to find new vaccines, and private entities like Pfizer are on the lookout for solutions like pills which can prevent the spread of the pandemic. Furthermore, distribution channels like hospitals are also on the lookout for promising solutions to tackle the growing shortage of oxygen for patients, while using semi-ventilators, as the shortage continues to widen. Furthermore, regions in the US have also witnessed freezing of pipelines expanding the shortage of oxygen further to drive further demand of oxygen processing machines. The rising demand for oxygen in both clinical research, and solutions to tackle on-ground reality remain major drivers in the global pharmaceutical and biotechnology machines market. The segment registered growth in 2018, as it registered the highest total revenues surpassing nitrous oxide, medical air, among other products. It will likely hold its lead, thanks to direct need arised due to the coronavirus pandemic. The medical air will remain the second-strongest segment, as pipelines freeze across cold regions, to make way for more growth for supply of medical air.
Credible Markets has emerged as a dependable source for the market research needs of businesses within a quick time span. We have collaborated with leading publishers of market intelligence and the coverage of our reports reserve spans all the key industry verticals and thousands of micro markets. The massive repository allows our clients to pick from recently published reports from a range of publishers that also provide extensive regional and country-wise analysis. Moreover, pre-booked research reports are among our top offerings.
Credible Markets Analytics
99 Wall Street 2124 New York, NY 10005
Contact No: +1(929)-450-2887
Email: [email protected]